<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 15, 2000
--------------------------------
MERCK & CO., Inc.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
New Jersey
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-3305 22-1109110
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
One Merck Drive, PO Box 100, Whitehouse Station, NJ 08889-0100
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (908) 423-1000
-----------------------------
<PAGE> 2
Item 7. Financial Statements and Exhibits
(c) Exhibits
<TABLE>
<S> <C> <C>
Exhibit 99(a) Press release issued Filed with
November 15, 2000 regarding this document
earnings guidance for fourth quarter
Exhibit 99(b) Remarks given by Raymond V. Gilmartin, Filed with
Chairman, President and Chief Executive this document
Officer of the Registrant, at The Credit Suisse
First Boston Annual Healthcare Conference
</TABLE>
Item 9. Regulation FD Disclosure
Incorporated by reference is a press release issued by the Registrant on
November 15, 2000, attached as Exhibit 99(a). Also incorporated by reference are
remarks given by Raymond V. Gilmartin, Chairman, President and Chief Executive
Officer of the Registrant, at The Credit Suisse First Boston Annual Healthcare
Conference, attached as Exhibit 99(b).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
MERCK & CO., Inc.
Date: November 15, 2000 By: /s/ Debra A. Bollwage
------------------------------
DEBRA A. BOLLWAGE
Assistant Secretary
<PAGE> 3
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit
Number Description
------ -----------
<S> <C>
99(a) Press release issued November 15, 2000 regarding earnings
guidance for fourth quarter
99(b) Remarks given by Raymond V. Gilmartin, Chairman, President and
Chief Executive Officer of the Registrant, at The Credit
Suisse First Boston Annual Healthcare Conference
</TABLE>
